Are you passionate about writing clean, efficient, and scalable code? Ready to drive innovation in drug discovery and development? ENPICOM is looking for a Senior Software Engineer to join our dynamic team in 's-Hertogenbosch. At ENPICOM, we empower groundbreaking biologics research with advanced data analysis and visualization solutions. Join our lean, highly skilled engineering team and contribute to a platform that handles Terabytes of data and thousands of analyses monthly. Learn more and apply now: https://lnkd.in/eFmbgkji #Hiring #SoftwareEngineering #AWS #Rust #Python #TechJobs
ENPICOM
Biotechnologisch onderzoek
Den Bosch, NB 2.072 volgers
We create innovative software solutions to analyze the immune repertoire, identify new insights and novel therapeutics
Over ons
ENPICOM is an innovative bioinformatics software engineering company delivering ground-breaking products and customized solutions to decode the immune system and improve human health. With a diverse team of over 25 professionals, we serve customers from all over the world, from academic research centers doing basic research related to the immune system to biotech and global pharmaceutical companies focusing on the discovery and development of novel immunotherapies and vaccines. For more details visit www.enpicom.com
- Website
-
https://enpicom.com
Externe link voor ENPICOM
- Branche
- Biotechnologisch onderzoek
- Bedrijfsgrootte
- 11 - 50 medewerkers
- Hoofdkantoor
- Den Bosch, NB
- Type
- Particuliere onderneming
- Opgericht
- 2015
- Specialismen
- Bioinformatics, Scientific Software, Interactive data visualization, Data science, Immunogenomics, TCR repertoire analysis, BCR repertoire analysis en Machine Learning
Locaties
-
Primair
Sint Janssingel 88
Den Bosch, NB 5211DA, NL
-
Startup Village Unit A.07
Science Park 608
Amsterdam, 1098 XH, NL
Medewerkers van ENPICOM
Updates
-
AI holds immense potential for biomedical research, but integrating it into existing #drugdiscovery workflows can be complicated. To maximize value from AI initiatives, it’s crucial to harmonize data collection, implement scalable storage solutions, efficiently manage AI model lifecycles, and foster ML adoption among lab scientists. Learn more: https://lnkd.in/eEVRfFB5 #MLOPs #AIintegration
-
-
In-depth information about your clones is vital when picking candidates. The Sequence Viewer, available throughout the IGX Platform, offers immediate access to all metadata about your clones, including the number and location of any sequence liabilities. With this information at your fingertips, you can make informed decisions faster. Looking to accelerate your biologics discovery? Schedule a personalized demo today: https://lnkd.in/eb2N3WZV #drugdiscovery #antibodies
-
Antibody humanization is a critical step in developing a therapeutic antibody drug candidate. Traditional humanization methods and publicly available online tools often face quality and throughput limitations. Meet GenovacAI powered by ENPICOM. Using advanced #DeepLearning-based algorithms, we humanize antibodies with high success rates. This enables scientists to effortlessly identify developable humanized candidates, with significant savings in cost and time. Learn more by watching our latest case study presentation or schedule a meeting with our experts to discuss your next project: https://lnkd.in/eTBQRdzU #AntibodyDiscovery #MachineLearning
-
-
Quality control is a crucial step in any analysis workflow. IGX Platform provides a detailed breakdown of read fates during clone annotation, allowing you to review and export discarded reads. This helps you troubleshoot your data and refine your clonal annotation settings, ensuring reliable and accurate results. Looking to accelerate your biologics discovery? Schedule a personalized demo today: https://lnkd.in/eyQ7vm9N #drugdiscovery #antibodies #qualitycontrol
-
-
Curious about which tool offers the most accurate PHRED scores for simulated reads? 👀 We conducted a comprehensive comparison of PHRED scores from reads generated by InSilicoSeq 2.0 and five other popular read simulation tools against real reads from Illumina MiSeq, NovaSeq, HiSeq, and NextSeq platforms. Discover our findings in the revised manuscript, now available on BioRxiv: https://lnkd.in/edaTgtAa #AIRRSeq #sequencing #bioinformatics #immunerepertoire
-
-
Efficient data organization is key to smooth workflows. With a powerful tagging system at its core, IGX Platform simplifies the process of grouping related files together, ensuring your data is neatly organized and readily accessible. Looking to accelerate and improve your #immunerepertoire data analysis? Schedule a personalized demo with us today: https://lnkd.in/eyQ7vm9N #drugdiscovery #datamanagement
-
-
Will you be at The AIRR Community Meeting VII this week? Come say hi to our team and see our poster on "Comparison of sequence- and structure-based antibody clustering approaches on simulated repertoire sequencing data." 🧬 📍 Booth 10 📍 Poster 40 Excited to meet you there! 🎉 #biotech #immunology #antibodydiscovery #airrc7 #machinelearning
-
-
ENPICOM heeft dit gerepost
The meeting of VAXPRED (Inno4Vac’s Subtopic 1) was successfully held in Porto (PT) on 31st May 2024! Partners discussed the scientific progress of this project aimed to build an #OpenAccess & cloud-based platform for predicting #vaccine efficacy. 💉 Discover the meeting highlights ▶️ https://lnkd.in/dGQUn-ii --- #AI, #BigData analysis, #Computational Modelling, #GerminalCenterModeling, #TCRsequencing, #BCRsequencing --- University of Oslo (UiO), Gunnveig Grodeland, INESC TEC - Associate Laboratory, ENPICOM, Helmholtz Centre for Infection Research, DTU - Technical University of Denmark, GSK, Sanofi, Sclavo Vaccines Association, Innovative Health Initiative (IHI) This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101007799. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
-
Attending #PEGSBoston? Make sure to stop by Booth #221 to meet Nicola Bonzanni, Piotr van Rijssel, and Ivan H.. Discover how we can collaborate to fast-track your #drugdiscovery success and don't forget to grab a delicious stroopwafel while you're there! 🍪 Interested in cutting-edge technology for antibody humanization? Visit Poster C093: Genovac OptiAb™ Powered by ENPICOM- A Deep Learning Tool and Service for Next Generation Antibody Humanization See you there! 👋 #deeplearning #antibodies #AI #machinelearning
-